Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 6 open reading frame 47 (C6orf47) encodes a protein found in the MHC class III locus on 6p21.33 and is predicted to be a trispanin transmembrane protein mainly localized in the endoplasmic reticulum[1][3][5]. It is ubiquitously (but variably) expressed across tissues, with highest RNA levels in the salivary gland and cerebellum, and is overexpressed in colon, bladder, ovary, and pancreas[1]. The function of C6orf47 is poorly characterized; available data suggest it may modulate immune or inflammatory processes, but it is not essential in macrophage lipid metabolism or hypoxic response—expression falls rather than rises under hypoxic conditions[1]. The protein is enriched in leucine, proline, and glycine, and contains three conserved transmembrane domains. Post-translational modifications include phosphorylation (sites: 34, 35, 71, 90), sumoylation (75, 114, 147), and O-linked β-N-acetylglucosamine (site: 60)[1]. The only reported molecular interaction is with fibroblast growth factor receptor 3 (FGFR3), detected at medium confidence through a two-hybrid assay[1]; the relevance of this interaction is unknown. Genetic variants in the C6orf47 locus have been implicated in susceptibility to celiac disease and potentially to non-Hodgkin’s lymphoma and early menopause, but this association is by genomic proximity and interlocus interaction, not by confirmed protein function[3]. There are no pathogenic single nucleotide polymorphisms (SNPs) directly attributable to C6orf47 function[1]. No drugs, mechanisms of action, biomarkers, or safety concerns related to C6orf47 have been reported in scientific literature as of September 2025[1][3][5].
None known; no drug mechanism described for this molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 6 open reading frame 47 (C6orf47).